1998
DOI: 10.1139/y98-064
|View full text |Cite
|
Sign up to set email alerts
|

Novel attributes of an androgenic steroid-mediated increase in cardiac end diastolic stiffness in rats

Abstract: Although cardiac early and mid-diastolic stiffness constants are well accepted as being modulated by alterations in myocyte active processes, increments in left ventricular end diastolic (LVED) stiffness (LVED k; g x cm(-2)) in classical pathological models of a reduced LVED k (e.g., diabetes mellitus (DM) and hypertension) are determined largely by the properties of the myocardial extracellular matrix (ECM). As such, increases in LVED k in the latter cardiac pathologies are insensitive to acute changes in car… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2000
2000
2010
2010

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Published data indicate that chronic use of AAS is directly related to an increase in number of cardiac myocytes (Marsh et al, 1998). According to Trifunovic et al (1995Trifunovic et al ( , 1998, chronic administration of high doses of anabolic androgenic steroids such as nandrolone decanoate, similar to those used by athletes, attributes to a decrease in compliance of the myocardium in the left ventricle, as well as changes in contractility and cardiac performance. In contrast, AAS administration, combined with physical training, has been reported to prevent cardiac hypertrophy in dogs submitted to endurance training (Moore, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…Published data indicate that chronic use of AAS is directly related to an increase in number of cardiac myocytes (Marsh et al, 1998). According to Trifunovic et al (1995Trifunovic et al ( , 1998, chronic administration of high doses of anabolic androgenic steroids such as nandrolone decanoate, similar to those used by athletes, attributes to a decrease in compliance of the myocardium in the left ventricle, as well as changes in contractility and cardiac performance. In contrast, AAS administration, combined with physical training, has been reported to prevent cardiac hypertrophy in dogs submitted to endurance training (Moore, 1998).…”
Section: Discussionmentioning
confidence: 99%